Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Blood-based, Point-of-need Assessment of CAR-T Vector Load in DLBCL Patients Undergoing Axicabtagene Ciloleucel (axi-cel) Therapy: A Multi-Site Study

Disease Sites:

Lymphoma

Staging:

N/A

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Oluwole, Olalekan

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

08-31-2023

Trial Type:

Basic Science

Protocol ID:

VICC-IDCTT23426

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available